“Exploiter les opportunités qui existent à l’interface des universités et de l'industrie”
LES CONFÉRENCIERS
Restez informés pour plus de détails!
Robert Déziel
Deputy Director chez Conseil de recherches en sciences naturelles et en génie du Canada (CRSNG)
NSERC’s Research Partnership Programs- Introducing The New Vintage!
Jean-Marc Juteau
Commissaire chez Cité de la Biotech
The Biotech City- an integrative hub
Anne Marinier
Chercheure principale et directrice de la chimie mèdicinale chez IRIC et Professeur associée chez Université de Montréal
IRIC Medicinal Chemistry Platform: Enabling Drug Development in an Academic Environment
Marc Janes
Senior Director-Business Development chez NuChem
Dr. Annie Castonguay
Professor chez Centre Armand-Frappier Santé Biotechnologie
Louis Vaillancourt
General Manager chez NMX Research and Solutions
Fragment-based Lead Discovery at NMX: A Compelling Strategy for Academic-Industry Partnership
Normand Voyer
Director du PROTEO, Professor titulaire chez Université Laval
Benoît Roberge-Vallieres
Spécialiste, développement des affaires-Ville de Quebec chez MITACS
Mitacs funding programs for R&D: Building partnerships between academia, industry and the world – to create a more innovative Canada
Joshua Pottel
President et CEO chez Molecular Forecaster
Accelerating Drug Discovery in Academia and Industry with Just a Few Clicks
Katherine Borden
Professeur chez Université de Montréal (UdeM), Chercheure principale, Unité de recherche en structure et fonction du noyau cellulaire chez IRIC
Targeting RNA metabolism in Cancer: From the bench to bedside and back again
Many cancers are characterized by a decoupling of the transcriptome from the proteome. This enables the cancer cell to implement a wide variety of changes to the proteome quickly. The eukaryotic translation initiation factor eIF4E provides a model system for such a strategy. Using a wide variety of methods ranging from NMR to clinical trials, we explore the utility and ramifications of targeting these pathways in the clinic by using a “bench to bedside and back" again approach.
Laurent Tillement
Attaché de recherche chez Servier Canada
Academic-Industry Partnership: the View from Servier Canada
Charles Calmettes
Professor chez Centre Armand Frappier Santé Biotechnologie
Protein Structure Determination by X-ray Crystallography